Efficacy of extracorporeal shock wave therapy plus platelet-rich plasma in carpal tunnel syndrome

Takeaway

  • The addition of extracorporeal shock wave therapy to platelet-rich plasma therapy does not improve outcomes in moderate carpal tunnel syndrome.

Why this matters

    As potential regenerative therapies for peripheral neuropathy, it was anticipated that combining extracorporeal shock wave therapy with platelet-rich plasma would improve outcomes. Further studies with multiple sessions of extracorporeal shock wave therapy and longer follow-up periods would indicate whether this combination is a viable option in the longer term.